The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
Open accessAbstract
Multiple clinical trials have shown the efficacy of adoptively transferred allogeneic antigen-specific T cells for the treatment of viral infections and relapsed hematologic malignancies. In contrast, the therapeutic potential of autologous antigen-specific T cells has yet to be established since it has been technically difficult to generate sufficient numbers of these T cells, ex vivo. A major obstacle to the success of this objective derives from our inability to simply and rapidly isolate and/or expand large numbers of highly efficient antigen presenting cells (APCs) for repetitive stimulations of antigen-specific T cells in vitro. We show that autologous CD40-activated B cells represent a readily available source of highly efficient APC that appear to have several important advantages over other APCs for ex vivo T cell expansion including: (a) methodological simplicity necessary to generate continuously large numbers of APCs from just 50 cm3 of peripheral blood without loss of APC function; (b) capacity to induce high peak T cell proliferation and interferon-gamma production without IL-10 production; (c) ease in cryopreservation; and (d) markedly reduced cost. We, therefore, contend that CD40-activated B cells are an alternative source of highly efficient APCs with which to generate antigen-specific T cells ex vivo for autologous adoptive immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Proliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804 · cited 1×
“Therefore, DCs have been selected as the “APC of choice” to generate antigen-specific T cells for immunotherapy (5, 6, 24, 25).”
MethodWalter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter-Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,554
Origin, maturation and antigen presenting function of dendritic cells
Cella, M., Sallusto, F., & Lanzavecchia, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80153-7 · Cited by 1,320
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
Tumor Antigens Recognized by T Lymphocytes
Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., & Van Pel, A. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002005 · Cited by 1,221
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992) · Science · doi:10.1126/science.1352912 · Cited by 1,201
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Romani, N., Reider, D., Heuer, M., Ebner, S., Kämpgen, E., Eibl, B., Niederwieser, D., & Schuler, G. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00078-6 · Cited by 1,091
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M. H., Castro-Malaspina, H., Childs, B. H., Gillio, A. P., Small, T. N., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301703 · Cited by 1,043
Heslop, H. E., Ng, C. Y. C., Li, C., Smith, C. A., Loftin, S. K., Krance, R. A., Brenner, M. K., & Rooney, C. M. (1996) · Nature Medicine · doi:10.1038/nm0596-551 · Cited by 821
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., & Falo, L. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.283 · Cited by 717
Bender, A., Sapp, M., Schuler, G., Steinman, R. M., & Bhardwaj, N. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00079-8 · Cited by 663
Inaba, K., Metlay, J. P., Crowley, M. T., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.631 · Cited by 657
The JAM test A simple assay for DNA fragmentation and cell death
Matzinger, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90325-a · Cited by 599
Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A. M., Fathman, C. G., Inaba, K., & Steinman, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.1169 · Cited by 551
Paglia, P., Chiodoni, C., Rodolfo, M., & Colombo, M. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.317 · Cited by 542
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
Liu, Y.-J., Barthélémy, C., Bouteiller, O. D., Arpin, C., Isabelle, D., & Banchereau, J. (1995) · Immunity · doi:10.1016/1074-7613(95)90048-9 · Cited by 347
Szabolcs, P., Moore, M. A. S., & Young, J. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5851 · Cited by 321
Constant, S., Schweitzer, N., West, J., Ranney, P., & Bottomly, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3734 · Cited by 302
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., & Moser, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240317 · Cited by 291
Young, J. W., Szabolcs, P., & Moore, M. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1111 · Cited by 277
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
Brossart, P., Goldrath, A. W., Butz, E. A., Martin, S., & Bevan, M. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3270 · Cited by 264
Principles for Adoptive T Cell Therapy of Human Viral Diseases
Riddell, S. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.545 · Cited by 248
Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D., Moore, M., Steinman, R., & Young, J. (1996) · Blood · doi:10.1182/blood.v87.11.4520.bloodjournal87114520 · Cited by 216
Schultze, J. L., Cardoso, A. A., Freeman, G. J., Seamon, M. J., Daley, J., Pinkus, G. S., Gribben, J. G., & Nadler, L. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8200 · Cited by 206
Self-citationRock, K. L., Rothstein, L., Gamble, S., & Fleischacker, C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.438 · Cited by 201
Mellado, B., Colomer, D., CASTEL, T., Muñoz-Mateu, M., Carballo, E., Galán, M., Mascaró, J. M., Corrons, J. V., Grau, J. J., & Estapé, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2091 · Cited by 180
Metlay, J. P., Puré, E., & Steinman, R. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60662-8 · Cited by 159
Analysis of MHC class II presentation of particulate antigens of B lymphocytes
Vidard, L., Kovacsovics-Bankowski, M., Kraeft, S. K., Chen, L. B., Benacerraf, B., & Rock, K. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2809 · Cited by 151
Dendritic cells hold promise for immunotherapy
Girolomoni, G., & Ricciardi‐Castagnoli, P. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01030-x · Cited by 134
Ke, Y., & Kapp, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1179 · Cited by 129
Visseren, M. J. W., van Elsas, A., van der Voort, E. I., Ressing, M. E., Kast, W. M., Schrier, P. I., & Melief, C. J. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3991 · Cited by 121
Dendritic Cells: Antigen Presentation, Accessory Function and Clinical Relevance
Steinman, R. M., Witmer-Pack, M. D., & Inaba, K. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2930-9_1 · Cited by 116
Dendritic Cells as Antigen Presenting Cellsin Vivo
Inaba, K., Metlay, J. P., Crowley, M. T., Witmer-Pack, M. D., & Steinman, R. M. (1990) · International Reviews of Immunology · doi:10.3109/08830189009056630 · Cited by 110
Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes.
Mitchell, R. N., Barnes, K. A., Grupp, S. A., Sanchez, M., Misulovin, Z., Nussenzweig, M. C., & Abbas, A. K. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1705 · Cited by 92
Schultze, J. L., Seamon, M. J., Michalak, S., Gribben, J. G., & Nadler, L. M. (1997) · Blood · doi:10.1182/blood.v89.10.3806 · Cited by 89
Self-citationCD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection
Riddell, S. R., Gilbert, M. J., & Greenberg, P. D. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90027-p · Cited by 43
Gollob, K. J., Nagelkerken, L. M., & Coffman, R. L. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231028 · Cited by 25
Cited by
Vonderheide, R. H., Hahn, W. C., Schultze, J. L., & Nadler, L. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80066-7 · Cited by 570
Self-citationCD40 agonist antibodies in cancer immunotherapy
Vonderheide, R. H. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-062518-045435 · Cited by 544
Vonderheide, R. H., Flaherty, K. T., Khalil, M., Stumacher, M. S., Bajor, D. L., Hutnick, N. A., Sullivan, P., Mahany, J. J., Gallagher, M., Kramer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3311 · Cited by 513
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
French, R. R., Chan, H. T. C., Tutt, A. L., & Glennie, M. J. (1999) · Nature Medicine · doi:10.1038/8426 · Cited by 426
Agonistic CD40 Antibodies and Cancer Therapy
Vonderheide, R. H., & Glennie, M. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2064 · Cited by 414
Metadata
- Authors
- Schultze, J. L., Michalak, S., Seamon, M. J., Dranoff, G., Jung, K., Daley, J., Delgado, J. C., Gribben, J. G., & Nadler, L. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-01
- Volume
- 100
- Issue
- 11
- Pages
- 2757-2765
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2028475115
- Cited by
- 355
- References
- 43
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.